Real Time - reuptake
News - reuptake
Antidepressant Use Linked to Higher Death Rates among ICU Patients
25 May 2012, 7:58 am
A new study is questioning the use of certain antidepressants, serotonin and norepinephrine
reuptake inhibitor (SNRI) or serotonin
reuptake inhibitors (SSRI), among seriously ill patients. The study, which was conducted by researchers from the Beth Israel Deaconess Medical Center in … Continue reading →
Antidepressant Use and Mortality in the ICU
22 May 2012, 8:27 am
Critically ill patients were more likely to die if they were taking the most commonly prescribed antidepressants when they were admitted to the intensive care unit (ICU), according to a new study.
Health Canada Updates Lexapro Label with Warning for Abnormal Heart Rhythm
9 May 2012, 2:23 pm
Health Canada has updated the Lexapro label with a warning about the drug’s link to abnormal heart rhythm. Lexapro (escitalopram), in the family of antidepressant medications known as Selective Serotonin
reuptake Inhibitors (SSRIs), is sold in Canada as Cipralex. Lexapro, … Continue reading →
Health Canada announces labelling update for Cipralex
7 May 2012, 11:42 am
Health Canada is informing Canadians of a labelling update for the prescription drug Cipralex (the brand name of the drug escitalopram) regarding a dose-related risk of abnormal heart rhythms. Cipralex is used to treat depression and belongs to a family of drugs known as Selective Serotonin
reuptake Inhibitors (SSRIs).
Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits
26 April 2012, 11:29 am
A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin
reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of … Continue reading →
World - reuptake
Sleepwalking Linked to Depression and OCD - YAHOO!
15 May 2012, 11:37 am
Specifically, medications used to treat depression and OCD, particularly selective serotonin
reuptake inhibitors such as Paxil, Zoloft or Lexapro, were shown to increase that risk. Previous research has also indicated a link between prescription sleeping ...
Almost 1 in 3 in U.S. have sleepwalked: study - YAHOO!
14 May 2012, 3:06 pm
Participants on antidepressants known as selective serotonin
reuptake inhibitors seemed to have a higher risk for sleepwalking, but the researchers said this could be explained by the conditions those drugs treat. Both major depression and OCD were also ...
Duloxetine: a review of safety reports - Xagena Medical News
10 May 2012, 11:39 pm
Duloxetine ( Cymbalta ) is a serotonin and norepinephrine
reuptake inhibitor ( SNRI ) for oral administration initially approved in August 2004 to treat major depressive disorder. Subsequently, FDA approved Duloxetine for the treatment of diabetic ...
